280. TRANSLATIONAL PHARMACOKINETIC-PHARMACODYNAMIC MODELING OF PRECLINICAL AND CLINICAL DATA OF THE TRIPLE REUPTAKE INHIBITOR JS1-1-01 TO DETERMINE THE RECOMMENDED PHASE II DOSEPublished on 2025-08-185 days ago